GFPD Awards Four Grants

August 6, 2013

The Global Foundation for Peroxisomal Disorders is pleased to announce the funding of four research projects in the field of peroxisomal disorders:

Dr. Nancy Braverman of McGill University in Montreal, Canada, was awarded $10,875.00 for the Canadian arm of a project entitled “A Pilot, Mult-Center Open-Label Trial Assessing the Safety and Efficacy of Betaine in Children with Peroxisome Biogenesis Disorders.”

Dr. William Rizzo of the University of Nebraska Medical Center was awarded $25,000 for the U.S. arm of the project entitled “A Pilot, Open-Label Trial Assessing the Safety and Efficacy of Betaine in Children with Peroxisome Biogenesis Disorders.”

Dr. Joseph Hacia of the University of Southern California was awarded $50,000 for his project entitled “Neural Cell Resources for PBD-ZSD Drug Testing.”

Dr. Steven Steinberg of Kennedy Krieger Institute in Maryland was awarded $25,000 for his project entitled “Pilot Treatment of the PEX1-G844D Mouse with Diosmetin.”

Grant recipients in attendance at the 2013 GFPD Family and Scientific Conference in Lincoln, Nebraska, last month were presented with their awards at the opening ceremonies.

 

 

 

 

 

 

Share on Facebook
Share on Twitter
Please reload

Featured Posts

PAUSE for PBD 2019! #PauseforPBD